Independent resource hub
Guides, comparisons, and research summaries for people trying to ask clearer questions about ibogaine and 5-MeO-DMT treatment.
Halcyon Spur organizes evidence, risks, regulation, and practical questions in one place. It is an information resource, not a clinical service, and it does not offer medical or legal advice.
Starting point
Featured guide
The central guide gathers the basic distinctions: what is known, what remains uncertain, where safety concerns arise, and why policy context changes what people may encounter. The main treatment questions overview is a useful place to begin when the terminology itself feels crowded.
For context on how this resource approaches uncertainty, evidence, and scope, the mission and editorial principles explain what Halcyon Spur is designed to cover.
Browse by need
These pathways are designed to make a complicated subject easier to examine. They do not assess an individual situation, recommend a provider, or substitute for qualified medical and legal guidance.
Plain-language explainers organize common questions about ibogaine, 5-MeO-DMT, treatment language, and research limits.
Structured comparisons distinguish evidence, claims, risks, regulation, and practical questions without reducing them to a simple verdict.
Research summaries help locate findings in context, including the difference between preliminary interest and established care.
Short definitions and recurring questions make it easier to recognize terms, gaps, and questions worth taking seriously.
Expandable learning sections
Research summaries distinguish between questions being studied and conclusions that can responsibly be drawn. Ibogaine is described by the ibogaine overview as a psychoactive alkaloid, while questions about use, outcomes, and risk require more than a definition.
Risk clarity is not an optional add-on. The resources identify serious questions around health history, interactions, psychological effects, and oversight, while avoiding individualized medical direction. The National Institute on Drug Abuse overview of psychedelic and dissociative drugs also notes that research on these substances is ongoing.
Legal and regulatory context is location-dependent and can change. Location-specific materials include questions people raise about ibogaine treatment in Utah, European ibogaine treatment context, and the practical setting around an ibogaine retreat in Mexico; none of these pages replaces checking current rules with an appropriate qualified source.
Tools for reading carefully
“Evidence before hype means keeping the difficult questions visible.”
Frequently asked questions
No. Halcyon Spur provides information services: guides, comparisons, research summaries, a glossary, and FAQ collections. It is not a clinic, medical provider, or licensed treatment center.
They organize questions about evidence, risk, regulation, practical context, and uncertainty around ibogaine and 5-MeO-DMT. They are intended to support careful reading, not to make a treatment decision for anyone.
Safety context matters because research and policy are evolving and these substances can involve serious medical, psychological, and legal considerations. A careful resource makes room for uncertainty instead of presenting treatment claims as settled.